HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pancytopenia after allogeneic bone marrow transplant due to copper deficiency.

Abstract
Pancytopenia occurring 1 year or later after allogeneic bone marrow transplantation typically prompts a primary consideration for relapse. We present the case of a 15-year old-girl who underwent transplantation for therapy-related myelodysplasia secondary to Ewing sarcoma treatment who developed pancytopenia with myelodysplasia 1 year after transplant due to copper deficiency. Copper deficiency is an important consideration in the evaluation of pancytopenia and myelodysplasia in pediatric patients.
AuthorsMichelle Hudspeth, Amy Turner, Nicole Miller, John Lazarchick
JournalJournal of pediatric hematology/oncology (J Pediatr Hematol Oncol) Vol. 36 Issue 4 Pg. 316-8 (May 2014) ISSN: 1536-3678 [Electronic] United States
PMID23652881 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Copper
Topics
  • Adolescent
  • Allografts
  • Bone Marrow Transplantation
  • Bone Neoplasms (blood, pathology, therapy)
  • Copper (blood, deficiency)
  • Female
  • Humans
  • Pancytopenia (blood, etiology)
  • Sarcoma, Ewing (blood, pathology, therapy)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: